Squamous Non-Small Cell Lung Cancer Therapeutics Market

List of Tables
Table 1. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends
Table 3. Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers
Table 4. Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges
Table 5. Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints
Table 6. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Squamous Non-Small Cell Lung Cancer Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Squamous Non-Small Cell Lung Cancer Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2021)
Table 15. Top Players of Squamous Non-Small Cell Lung Cancer Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Squamous Non-Small Cell Lung Cancer Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Squamous Non-Small Cell Lung Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Ascenta Therapeutics, Inc. Company Details
Table 31. Ascenta Therapeutics, Inc. Business Overview
Table 32. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 33. Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Ascenta Therapeutics, Inc. Recent Development
Table 35. AstraZeneca Plc Company Details
Table 36. AstraZeneca Plc Business Overview
Table 37. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 38. AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 39. AstraZeneca Plc Recent Development
Table 40. AVEO Pharmaceuticals, Inc. Company Details
Table 41. AVEO Pharmaceuticals, Inc. Business Overview
Table 42. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 43. AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 44. AVEO Pharmaceuticals, Inc. Recent Development
Table 45. Bayer AG Company Details
Table 46. Bayer AG Business Overview
Table 47. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 48. Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Bayer AG Recent Development
Table 50. BIND Therapeutics, Inc. Company Details
Table 51. BIND Therapeutics, Inc. Business Overview
Table 52. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 53. BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 54. BIND Therapeutics, Inc. Recent Development
Table 55. Boehringer Ingelheim GmbH Company Details
Table 56. Boehringer Ingelheim GmbH Business Overview
Table 57. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 58. Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Boehringer Ingelheim GmbH Recent Development
Table 60. Bristol-Myers Squibb Company Company Details
Table 61. Bristol-Myers Squibb Company Business Overview
Table 62. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 63. Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Bristol-Myers Squibb Company Recent Development
Table 65. Eli Lilly and Company Company Details
Table 66. Eli Lilly and Company Business Overview
Table 67. Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 68. Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Eli Lilly and Company Recent Development
Table 70. F. Hoffmann-La Roche Ltd. Company Details
Table 71. F. Hoffmann-La Roche Ltd. Business Overview
Table 72. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 73. F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 74. F. Hoffmann-La Roche Ltd. Recent Development
Table 75. Five Prime Therapeutics, Inc. Company Details
Table 76. Five Prime Therapeutics, Inc. Business Overview
Table 77. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 78. Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Five Prime Therapeutics, Inc. Recent Development
Table 80. Genentech, Inc. Company Details
Table 81. Genentech, Inc. Business Overview
Table 82. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 83. Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Genentech, Inc. Recent Development
Table 85. Incyte Corporation Company Details
Table 86. Incyte Corporation Business Overview
Table 87. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 88. Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Incyte Corporation Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 93. Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Johnson & Johnson Recent Development
Table 95. MacroGenics, Inc. Company Details
Table 96. MacroGenics, Inc. Business Overview
Table 97. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 98. MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 99. MacroGenics, Inc. Recent Development
Table 100. Novartis AG Company Details
Table 101. Novartis AG Business Overview
Table 102. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 103. Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 104. Novartis AG Recent Development
Table 105. Oncogenex Pharmaceuticals, Inc. Company Details
Table 106. Oncogenex Pharmaceuticals, Inc. Business Overview
Table 107. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 108. Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 109. Oncogenex Pharmaceuticals, Inc. Recent Development
Table 110. PsiOxus Therapeutics Limited Company Details
Table 111. PsiOxus Therapeutics Limited Business Overview
Table 112. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product
Table 113. PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 114. PsiOxus Therapeutics Limited Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Squamous Non-Small Cell Lung Cancer Therapeutics Product Picture
Figure 2. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Share in Global 2017-2028
Figure 7. Squamous Non-Small Cell Lung Cancer Therapeutics Report Years Considered
Figure 8. Product Picture of BMS-906024
Figure 9. Product Picture of Buparlisib Hydrochloride
Figure 10. Product Picture of FP-1039
Figure 11. Product Picture of Ipilimumab
Figure 12. Product Picture of JNJ-42756493
Figure 13. Product Picture of Lenvatinib
Figure 14. Product Picture of Others
Figure 15. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type in 2022 & 2028
Figure 16. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 17. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
Figure 18. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type in 2022 & 2028
Figure 19. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 20. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
Figure 21. Product Picture of Research Center
Figure 22. Product Picture of Hospital
Figure 23. Product Picture of Clinic
Figure 24. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application in 2022 & 2028
Figure 25. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 26. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
Figure 27. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application in 2022 & 2028
Figure 28. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 29. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
Figure 30. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. U.S. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Canada Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 34. Germany Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. France Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. U.K. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Italy Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Russia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 40. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Australia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Taiwan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Indonesia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Thailand Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Malaysia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Philippines Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Argentina Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 55. Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. U.A.E Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 58. Ascenta Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 59. AstraZeneca Plc Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 60. AVEO Pharmaceuticals, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 61. Bayer AG Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 62. BIND Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 63. Boehringer Ingelheim GmbH Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 66. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 67. Five Prime Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 68. Genentech, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 69. Incyte Corporation Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 70. Johnson & Johnson Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 71. MacroGenics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 72. Novartis AG Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 73. Oncogenex Pharmaceuticals, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 74. PsiOxus Therapeutics Limited Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed